These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 34534465)

  • 1. Proteogenomic characterization of pancreatic ductal adenocarcinoma.
    Cao L; Huang C; Cui Zhou D; Hu Y; Lih TM; Savage SR; Krug K; Clark DJ; Schnaubelt M; Chen L; da Veiga Leprevost F; Eguez RV; Yang W; Pan J; Wen B; Dou Y; Jiang W; Liao Y; Shi Z; Terekhanova NV; Cao S; Lu RJ; Li Y; Liu R; Zhu H; Ronning P; Wu Y; Wyczalkowski MA; Easwaran H; Danilova L; Mer AS; Yoo S; Wang JM; Liu W; Haibe-Kains B; Thiagarajan M; Jewell SD; Hostetter G; Newton CJ; Li QK; Roehrl MH; Fenyö D; Wang P; Nesvizhskii AI; Mani DR; Omenn GS; Boja ES; Mesri M; Robles AI; Rodriguez H; Bathe OF; Chan DW; Hruban RH; Ding L; Zhang B; Zhang H;
    Cell; 2021 Sep; 184(19):5031-5052.e26. PubMed ID: 34534465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
    Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
    J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
    ;
    Cancer Cell; 2017 Aug; 32(2):185-203.e13. PubMed ID: 28810144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
    Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
    Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
    Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
    J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A
    BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
    Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
    Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma.
    Yang J; Lin P; Yang M; Liu W; Fu X; Liu D; Tao L; Huo Y; Zhang J; Hua R; Zhang Z; Li Y; Wang L; Xue J; Li H; Sun Y
    Genome Biol; 2021 Jan; 22(1):4. PubMed ID: 33397441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
    Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
    Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
    Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
    J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell transcriptome reveals the heterogeneity of malignant ductal cells and the prognostic value of REG4 and SPINK1 in primary pancreatic ductal adenocarcinoma.
    Ji Y; Xu Q; Wang W
    PeerJ; 2024; 12():e17350. PubMed ID: 38827297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.
    Nones K; Waddell N; Song S; Patch AM; Miller D; Johns A; Wu J; Kassahn KS; Wood D; Bailey P; Fink L; Manning S; Christ AN; Nourse C; Kazakoff S; Taylor D; Leonard C; Chang DK; Jones MD; Thomas M; Watson C; Pinese M; Cowley M; Rooman I; Pajic M; ; Butturini G; Malpaga A; Corbo V; Crippa S; Falconi M; Zamboni G; Castelli P; Lawlor RT; Gill AJ; Scarpa A; Pearson JV; Biankin AV; Grimmond SM
    Int J Cancer; 2014 Sep; 135(5):1110-8. PubMed ID: 24500968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
    Clark DJ; Dhanasekaran SM; Petralia F; Pan J; Song X; Hu Y; da Veiga Leprevost F; Reva B; Lih TM; Chang HY; Ma W; Huang C; Ricketts CJ; Chen L; Krek A; Li Y; Rykunov D; Li QK; Chen LS; Ozbek U; Vasaikar S; Wu Y; Yoo S; Chowdhury S; Wyczalkowski MA; Ji J; Schnaubelt M; Kong A; Sethuraman S; Avtonomov DM; Ao M; Colaprico A; Cao S; Cho KC; Kalayci S; Ma S; Liu W; Ruggles K; Calinawan A; Gümüş ZH; Geiszler D; Kawaler E; Teo GC; Wen B; Zhang Y; Keegan S; Li K; Chen F; Edwards N; Pierorazio PM; Chen XS; Pavlovich CP; Hakimi AA; Brominski G; Hsieh JJ; Antczak A; Omelchenko T; Lubinski J; Wiznerowicz M; Linehan WM; Kinsinger CR; Thiagarajan M; Boja ES; Mesri M; Hiltke T; Robles AI; Rodriguez H; Qian J; Fenyö D; Zhang B; Ding L; Schadt E; Chinnaiyan AM; Zhang Z; Omenn GS; Cieslik M; Chan DW; Nesvizhskii AI; Wang P; Zhang H;
    Cell; 2019 Oct; 179(4):964-983.e31. PubMed ID: 31675502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes.
    Hyeon DY; Nam D; Han Y; Kim DK; Kim G; Kim D; Bae J; Back S; Mun DG; Madar IH; Lee H; Kim SJ; Kim H; Hyun S; Kim CR; Choi SA; Kim YR; Jeong J; Jeon S; Choo YW; Lee KB; Kwon W; Choi S; Goo T; Park T; Suh YA; Kim H; Ku JL; Kim MS; Paek E; Park D; Jung K; Baek SH; Jang JY; Hwang D; Lee SW
    Nat Cancer; 2023 Feb; 4(2):290-307. PubMed ID: 36550235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
    Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD
    Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma.
    Chen DT; Davis-Yadley AH; Huang PY; Husain K; Centeno BA; Permuth-Wey J; Pimiento JM; Malafa M
    PLoS One; 2015; 10(8):e0133562. PubMed ID: 26247463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.
    You N; Li J; Gong Z; Huang X; Wang W; Wang L; Wu K; Zheng L
    Mol Carcinog; 2017 Feb; 56(2):607-624. PubMed ID: 27350032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma.
    Li F; Si W; Xia L; Yin D; Wei T; Tao M; Cui X; Yang J; Hong T; Wei R
    Mol Cancer; 2024 May; 23(1):90. PubMed ID: 38711083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.